Dr. Neha Jain

About

I am a PhD in Life Sciences with extensive research experience in molecular oncology, non-coding RNA biology, and cancer therapeutics. I have authored 9+ peer-reviewed SCI publications in reputed international journals, demonstrating strong expertise in scientific writing, data interpretation, and research communication.
My work has focused on understanding molecular mechanisms of tumorigenesis and drug resistance using advanced molecular biology and bioinformatics approaches. Through my research journey, I have developed a strong ability to translate complex scientific concepts into clear, concise, and impactful content.
I am currently seeking remote opportunities in scientific writing, medical writing, and research analysis where I can contribute my expertise in content development, literature review, and scientific communication.
Key Skills: • Scientific & Medical Writing
• Manuscript Preparation & Editing
• Literature Review & Data Analysis
• Molecular Biology & Cancer Research
• Bioinformatics Tools

Employment

Employment history is unavailable.

Education

• National Institute of Technology Rourkela Doctor of Philosophy
  2016 - 2021
• Ranchi Women's College B.Sc. Biotechnology
  2010 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Non‐coding RNAs and their cross‐talks impacting reproductive health of women
  WIREs RNA 2022 DOI: 10.1002/wrna.1695
  +Save
• Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma
  Gene 2022 DOI: 10.1016/j.gene.2021.145988
  +Save
• miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux
  DNA Repair 2022 DOI: 10.1016/j.dnarep.2021.103259
  +Save
• piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
  Communications Biology 2021 DOI: 10.1038/s42003-021-02844-1
  +Save
• Restoration of microRNA-197 expression suppresses oncogenicity in fibrosarcoma through negative regulation of RAN.
  IUBMB life 2020 DOI: 10.1002/iub.2240
  +Save
• piR-39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma.
  Biology of the cell 2020 DOI: 10.1111/boc.201900063
  +Save
• PIWI-interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells.
  Journal of cellular physiology 2019 DOI: 10.1002/jcp.29136
  +Save
• miR-197-5p inhibits sarcomagenesis and induces cellular senescence via repression of KIAA0101.
  Molecular carcinogenesis 2019 DOI: 10.1002/mc.23021
  +Save
• Small RNA proteome as disease biomarker: An incognito treasure of clinical utility
  AGO-Driven Non-Coding RNAs 2019 DOI: 10.1016/b978-0-12-815669-8.00005-1
  +Save
• Tumor suppressive activity of PIWI-interacting RNA in human fibrosarcoma mediated through repression of RRM2.
  Molecular carcinogenesis 2018 DOI: 10.1002/mc.22932
  +Save